More on CGTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+54.5% Growth)
- Ratings (8.6 Score)

Upcoming Events

- Earnings (8/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Cognition Therapeutics, Inc. (NQ:CGTX)
Delayed: 0.96 +0.02 (2.13%)
Prev. Close $0.94  
Open$0.94 
52 Wk High$ 
52 Wk Low$ 
Day High$0.98 
Day Low$0.92 
P/E N/A  
EPS$ 
Volume468,029 


Jul 13, 2026 07:30 AM Cognition Therapeutics Participating in Fireside Chat at B. Riley Securities' Mind, Muscle & Vision Summit
Jul 1, 2026 07:05 AM H.C. Wainwright Reiterates Buy Rating on Cognition Therapeutics (CGTX)
Jun 24, 2026 07:39 AM Form 8-K COGNITION THERAPEUTICS For: Jun 24
Jun 24, 2026 07:30 AM FDA aligns with Cognition Therapeutics on Phase 3 DLB psychosis trial
Jun 24, 2026 07:30 AM Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes
Jun 22, 2026 05:18 PM Form 4 COGNITION THERAPEUTICS For: Jun 17 Filed by: Khattar Jack A.
Jun 22, 2026 05:17 PM Form 4 COGNITION THERAPEUTICS For: Jun 17 Filed by: Monia Brett P
Jun 22, 2026 05:14 PM Form 4 COGNITION THERAPEUTICS For: Jun 17 Filed by: Wallace Peggy
Jun 22, 2026 05:13 PM Form 4 COGNITION THERAPEUTICS For: Jun 17 Filed by: RICHSTONE ELLEN B
Jun 22, 2026 04:00 PM Form 4 COGNITION THERAPEUTICS For: Jun 17 Filed by: Bios Equity Partners, LP
View All Articles

Entities mentioned with CGTX

View All Entities